Virtu KCG Holdings’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$104K Sell
41,972
-30,175
-42% -$74.8K ﹤0.01% 2396
2017
Q1
$164K Buy
72,147
+21,382
+42% +$48.6K ﹤0.01% 2503
2016
Q4
$108K Buy
50,765
+19,665
+63% +$41.8K ﹤0.01% 2868
2016
Q3
$104K Buy
+31,100
New +$104K ﹤0.01% 2611
2016
Q2
Sell
-20,130
Closed -$67K 3668
2016
Q1
$67K Sell
20,130
-104,224
-84% -$347K ﹤0.01% 2394
2015
Q4
$440K Buy
124,354
+105,643
+565% +$374K 0.01% 1350
2015
Q3
$94K Sell
18,711
-27,702
-60% -$139K ﹤0.01% 2377
2015
Q2
$298K Buy
+46,413
New +$298K 0.01% 1670
2015
Q1
Sell
-43,061
Closed -$332K 3604
2014
Q4
$332K Buy
43,061
+953
+2% +$7.35K 0.01% 1521
2014
Q3
$315K Sell
42,108
-3,046
-7% -$22.8K 0.01% 1591
2014
Q2
$436K Buy
45,154
+6,558
+17% +$63.3K 0.01% 1369
2014
Q1
$320K Buy
38,596
+23,077
+149% +$191K ﹤0.01% 1398
2013
Q4
$131K Sell
15,519
-105,568
-87% -$891K ﹤0.01% 2140
2013
Q3
$965K Buy
+121,087
New +$965K 0.01% 686